Advertisement

Topics

Right-To-Try Drug Bill Defeated in House

20:00 EDT 13 Mar 2018 | BioSpace

Federal right-to-try legislation that would have allowed terminally ill patients access to experimental therapies without approval from the U.S. Food and Drug Administration failed to muster enough support in the U.S. House of Representatives.

Original Article: Right-To-Try Drug Bill Defeated in House

NEXT ARTICLE

More From BioPortfolio on "Right-To-Try Drug Bill Defeated in House"

Advertisement
Quick Search
Advertisement
Advertisement